Founded in 1989, Integra LifeSciences is a global medical technology leader dedicated to restoring lives through innovative products in neurosurgery and tissue reconstruction. The company is known for its gold-standard portfolio including dermal regeneration templates, dural grafts, nerve guides, and surgical instruments, trusted by healthcare professionals worldwide. Integra has grown through strategic acquisitions, including the Codman neurosurgery business in 2017 and Acclarent in 2024, expanding its reach in specialty surgery and ENT.
AdvaMed Code of Ethics
Compliance program
MedTech Europe Code of Ethical Business Practice
Compliance program